Citizens Financial Group Inc Annexon, Inc. Transaction History
Citizens Financial Group Inc
- $7.13 Billion
- Q3 2025
A detailed history of Citizens Financial Group Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Citizens Financial Group Inc holds 40,000 shares of ANNX stock, worth $114,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,000
Previous 35,000
14.29%
Holding current value
$114,400
Previous $84,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ANNX
# of Institutions
151Shares Held
101MCall Options Held
88.6KPut Options Held
32.5K-
Satter Management Co., L.P.7.41MShares$21.2 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$20 Million1.13% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$18 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.84MShares$16.7 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $136M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...